| Fiscal Year End | Company Status | Exempt Flag |
| March 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 23/Apr/2004 | 1/Oct/2020 | Canada | British Columbia | Business Corporations Act |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Research and Development of Pharmaceutical Products
| (not available)
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *PBS | *Pacgen Life Science Corporation | TSX Venture | DELIST |
| *PGA | *Pacgen Biopharmaceuticals Corporation | TSX Venture | DELIST |
| *PGA | *Pacgen Biopharmaceuticals Corporation old | TSX Venture | DELIST |
|
|
| Name History | From | To |
| *Pacgen Life Science Corporation | 1/May/2012 | 1/Oct/2020 |
| *Pacgen Biopharmaceuticals Corporation | 12/Oct/2006 | 30/Apr/2012 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
